Funder
Gilead Sciences
National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Bristol-Myers Squibb
Pfizer
Subject
Anesthesiology and Pain Medicine,Rheumatology
Reference41 articles.
1. SARS-CoV-2 infection and COVID-19 outcomes in rheumatic disease: a systematic literature review and meta-analysis;Conway;Arthritis Rheumatol,2021
2. Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US 'hot spot';D'Silva;Ann Rheum Dis,2020
3. Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study;Bower;Ann Rheum Dis,2021
4. COVID-19 outcomes in patients with systemic autoimmune rheumatic diseases compared to the general population: a US multicenter;D'Silva;Comparat Cohort Study. Arthritis Rheumatol,2021
5. American College of Rheumatology Guidance for the management of rheumatic disease in adult patients during the COVID-19 pandemic: version 3;Mikuls;Arthritis Rheumatol,2021
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献